Microbiomes Market by Application and Geography - Forecast and Analysis 2021-2025

  • Published: May 2021
  • Pages: 120
  • SKU: IRTNTR41199

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The microbiomes market has the potential to grow by USD 713.01 million during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 24.23%.

This microbiomes market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by application (therapeutics and diagnostics) and geography (North America, Europe, Asia, and ROW). The microbiomes market report also offers information on several market vendors, including 4D pharma Plc, ENTEROME SA, Evelo Biosciences Inc., Ferring Pharmaceuticals AS, Osel Inc., Second Genome Therapeutics, Seres Therapeutics Inc., Synlogic Inc., Synthetic Biologics Inc., and Vedanta Biosciences Inc. among others.

What will the Microbiomes Market Size be in 2021?


Browse TOC and LoE with selected illustrations and example pages of Microbiomes Market

 Get Your FREE Sample Now!

Microbiomes Market: Key Drivers and Trends

The increasing prevalence of diseases is notably driving the microbiomes market growth, although factors such as challenges related to manufacturing and formulation may impede market growth. To unlock information on the key market drivers and the COVID-19 pandemic impact on the microbiomes industry get your FREE report sample now.


  • The high incidence rate of diseases has increased the need for developing a drug candidate that can efficiently treat such diseases and reduce healthcare expenditure.
  • Microbiome therapeutics and microbiome-based technology platforms have emerged as potential candidates for meeting such requirements.
  • Microbiome therapeutics are known to modulate gut microbiomes, which can substantially improve the responses in numerous forms of cancer therapies.
  • Many therapeutic manufacturers are focusing on using microbiome therapies to accelerate the treatments of diabetes and obesity.
  • Such benefits of microbiome therapies have increased the need for their development and commercialization, which has promoted revenue growth in the microbiome market. 
  • The understanding of the composition and functions of gut microbiota has significantly improved owing to technological advances, which are benefiting process workflows in microbiome discoveries, diagnostics, and therapeutics.
  • Researchers are benefitting by using novel methods for selective microbiome modulation, including antibiotic treatment, bacteriophage therapy, dietary supplementation, fecal microbiota transplantation (FMT), and probiotic microbial interventions.
  • These technologies are providing substantial opportunities to specifically control the functions and composition of the gut microbial community.
  • The growing use of such advanced technologies in microbiome research and studies is simplifying workflows of microbiome-based discoveries, diagnostics, and therapeutics, thereby driving the growth of the microbiome market.

This microbiomes market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. Get detailed insights on the trends and challenges, which will help companies evaluate and develop growth strategies.

Who are the Major Microbiomes Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:


  • 4D pharma Plc
  • Evelo Biosciences Inc.
  • Ferring Pharmaceuticals AS
  • Osel Inc.
  • Second Genome Therapeutics
  • Seres Therapeutics Inc.
  • Synlogic Inc.
  • Synthetic Biologics Inc.
  • Vedanta Biosciences Inc.


The microbiomes market is concentrated and the vendors are deploying growth strategies such as strategic alliances and collaborations to compete in the market. Click here to uncover other successful business strategies deployed by the vendors. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Download a free sample of the microbiomes market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Microbiomes Market?


For more insights on the market share of various regions Request for a FREE sample now!

46% of the market’s growth will originate from North America during the forecast period. The US is a key market for microbiomes in North America. Market growth in North America will be faster than the growth of the market in other regions.

The increasing focus on microbiome-based clinical research and the growing prevalence of gastrointestinal and non-gastrointestinal diseases will facilitate the microbiomes market growth in North America over the forecast period. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report.

What are the Revenue-generating Application Segments in the Microbiomes Market?


To gain further insights on the market contribution of various segments Request for a FREE sample

The microbiomes market share growth by the therapeutics segment will be significant during the forecast period. Fetch actionable market insights on post COVID-19 impact on each segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the microbiomes market size.



Request for a FREE sample

What are the Key Factors Covered in this Microbiomes Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive microbiomes market growth during the next five years
  • Precise estimation of the microbiomes market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the microbiomes industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of microbiomes market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.


Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases


Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts



  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis


  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
The microbiomes market growth will increase by $544.72 million during 2019-2024.
The microbiomes market is expected to grow at a CAGR of 29.66% during 2019-2024.
Technavio has segmented the microbiomes market by application (Therapeutics and Diagnostics) and geographic (North America, Europe, and Asia).
4D pharma Plc, ENTEROME SA, Evelo Biosciences Inc., Ferring International Center SA, Osel Inc., Second Genome Inc., Seres Therapeutics Inc., Synlogic Inc., Synthetic Biologics Inc., Vedanta Biosciences Inc. are a few of the key vendors in the microbiomes market.
North America will register the highest growth rate of 56.30% among the other regions. Therefore, the microbiomes market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
The key factors driving the microbiomes market growth are:
  • Increasing prevalence of diseases
  • Significant number of collaborations for developing microbiome therapeutics
The microbiomes market vendors should focus on grabbing business opportunities from the therapeutics segment as it accounted for the largest market share in the base year.
Safe and Secure SSL Encrypted

Single User:

2500 USD

Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase

Technavio's SUBSCRIPTION platform

Register for a free trial today and gain instant access to 17,000+ market research reports.


Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report

What other custmores say

17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>